• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Hygienic Packaging Technology

    Trends in Solid Oral Dosage Delivery

    5 Reasons Paper Has No Place in Contract Manufacturing

    Injectable Drug Delivery Trends

    Pharmaceutical Manufacturing Equipment Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Iontas and Fair Journey Biologics Partner with Quell Therapeutics

    Vetter Establishes Office in China

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Vetter Establishes Office in China

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Reed-Lane Facility Virtual Tour

    Hygienic Packaging Technology

    Reshaping the Pharmaceutical Supply Chain

    Serialization: Level 5 Solution

    Covectra Introduces Next-Gen Serialization Solution
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Vetter Establishes Office in China

    Data Management Trends

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Cytovance Biologics

    Reed-Lane

    Almac Group

    Adare Pharma Solutions

    Baxter BioPharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    PCI Pharma Services

    Almac Group

    Reed-Lane

    Baxter BioPharma Solutions

    Cytovance Biologics
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Catalent, Bridge Therapeutics Execute Exclusive License Agreement

    To utilize Catalent’s Zydis orally disintegrating tablet (ODT) technology for opioid addiction therapeutic product

    Related CONTENT
    • Parexel Adds Experts to Regulatory Consulting Group
    • Catalent, Ethicann Partner on Fast-Dissolve Treatment
    • SK Bio Gains FDA Approval for XCOPRI
    • Catalent, BeiGene Enter Long-Term Supply Agreement
    • Biopharma Over 20 Years
    12.10.19
    Catalent has completed clinical production of Bridge Therapeutics Inc.’s opioid addiction therapeutic product, BT-219, and executed an Exclusive Licensing Agreement to use Catalent’s Zydis orally disintegrating tablet (ODT) technology. Bridge intends to seek approval from the U.S. FDA for BT-219 under the 505(b)(2) regulatory submission pathway as well as a possible future single entity buprenorphine product.

    Catalent’s Zydis ODT technology is a unique, freeze-dried tablet that disperses almost instantly in the mouth without water. Zydis offers advantages over conventional oral dosage forms, including improved patient compliance, adherence and convenience. Bridge’s exclusive license of the Zydis technology will initially apply to the U.S., with the potential to expand to other nations.

    BT-219, or Bunalz, is an investigational new drug (IND) which applies the Zydis delivery technology to buprenorphine and naloxone, which are the active ingredients in the Suboxone prescription medication for opioid addiction. Buprenorphine, a Schedule III medication, is considered safer and less addictive than methadone, which is classified as a Schedule II medication. It has also been shown that buprenorphine is six-times safer than methadone with regard to overdose risk among the general population.

    “Catalent has a proven track record in working with partners to bring new therapies to market quickly and we look forward to working with Bridge as they pursue approval for this important and exciting new development product,” said Jonathan Arnold, president of Catalent’s Oral and Specialty Delivery business unit. He added, “The Zydis technology platform has been shown to be very versatile and effective in developing easy-to-administer dose forms for innovators and to date, more than 36 products have been launched using Zydis technology in over 60 countries.”

    Dr. Greg Sullivan, chief medical officer of Bridge Therapeutics, said, “This new formulation will provide improved administration characteristics. With many formulations being unpleasant to patients, this fast-dispersing Zydis formulation could potentially increase compliance with Medication-Assisted Treatment (MAT) and thus better clinical outcomes”. He added, “In addition to assisting the needs of the general population, utilizing the Zydis formulation technology lessens the chance of an institutionalized patient being able to divert the medication for untoward purposes.”

    Catalent’s 250,000 sq. ft. site in Swindon, U.K. houses the company’s Zydis development and manufacturing operation, which produces over one billion tablets annually and employs more than 600 people. In March 2019, Catalent announced a $27 million investment to commercialize its next-generation ODT technology, Zydis Ultra, which allows an increased drug load and taste masking to be incorporated into the Zydis dosage form.
     

     
    Related Searches
    • www.contractpharma.com
    • production
    • it
    • prescription
    Suggested For You
    Parexel Adds Experts to Regulatory Consulting Group Parexel Adds Experts to Regulatory Consulting Group
    Catalent, Ethicann Partner on Fast-Dissolve Treatment Catalent, Ethicann Partner on Fast-Dissolve Treatment
    SK Bio Gains FDA Approval for XCOPRI SK Bio Gains FDA Approval for XCOPRI
    Catalent, BeiGene Enter Long-Term Supply Agreement  Catalent, BeiGene Enter Long-Term Supply Agreement
    Biopharma Over 20 Years Biopharma Over 20 Years
    Catalent Appoints Corporate Development and Science Leaders Catalent Appoints Corporate Development and Science Leaders
    Contract Pharma’s 20th Anniversary Series: Catalent Contract Pharma’s 20th Anniversary Series: Catalent
    Catalent Biologics Launches GPExR Boost Cell Line Expression Technology Catalent Biologics Launches GPExR Boost Cell Line Expression Technology
    Cycle, Catalent to Develop Formulations Targeting Rare Disorders Cycle, Catalent to Develop Formulations Targeting Rare Disorders
    Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future
    Catalent Appoints Germany GM Catalent Appoints Germany GM
    Contracting And Outsourcing Exhibitor List Contracting And Outsourcing Exhibitor List
    Quality Metrics Feedback Quality Metrics Feedback
    FDA Extends CRADA with CluePoints FDA Extends CRADA with CluePoints
    NIIMBL, FDA to Advance Innovation in Bio Manufacturing NIIMBL, FDA to Advance Innovation in Bio Manufacturing

    Related Breaking News

    • APIs | Breaking News | Formulation Development | Industry News
      Tris Pharma, Athena Bioscience Enter Exclusive License Agreement

      Tris Pharma, Athena Bioscience Enter Exclusive License Agreement

      Athena gains exclusive rights to commercialize a long-acting antihypertensive product developed using Tris' proprietary technology.
      Kristin Brooks 02.22.21

    • Breaking News | Formulation Development | Industry News | Promotions & Moves
      Novartis Vet Joins CDMO Sai Life Sciences

      Novartis Vet Joins CDMO Sai Life Sciences

      Mahavir Prashad named as vice president of early phase process development.
      Tim Wright, Editor, Contract Pharma 02.17.21

    • APIs | Breaking News | Drug Development | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
      Lonza Expands Solid Small Molecule Services

      Lonza Expands Solid Small Molecule Services

      To encompass all aspects of solid form screening and characterization of small molecule APIs.
      Kristin Brooks 02.16.21


    • Breaking News | Formulation Development | Industry News | Methods Development
      Adare Pharma Solutions Opens New Small-Scale Lab

      Adare Pharma Solutions Opens New Small-Scale Lab

      Vandalia, OH lab offers customizable, flexible systems designed to expedite formulation and process development services.
      Kristin Brooks 01.26.21

    • Breaking News | Formulation Development | Industry News
      Hovione Launches ASD-HIPROS

      Hovione Launches ASD-HIPROS

      Advanced tool designed to identify optimal and commercially viable Amorphous Solid Dispersions formulation by Spray Drying.
      Contract Pharma Staff 01.12.21

    • Biologics, Proteins, Vaccines | Breaking News | Fill/Finish | Formulation Development | Industry News
      Moderna, Recipharm Enter COVID-19 Vax Mfg. Agreement

      Moderna, Recipharm Enter COVID-19 Vax Mfg. Agreement

      Recipharm to provide aseptic drug product manufacturing and fill-finish of Moderna’s COVID-19 vaccine outside of the U.S.
      Contract Pharma Staff 01.04.21


    • Breaking News | Drug Development | Formulation Development | Industry News
      Vectura, Kinaset Partner to Develop Asthma Treatment

      Vectura, Kinaset Partner to Develop Asthma Treatment

      Licenses VR588 to Kinaset, Vectura will provide formulation development services to support Phase I studies and ultimately commercialization.
      Contract Pharma Staff 11.30.20

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Formulation Development | Industry News
      Lonza Expands Development, Mfg. Capabilities at Bend Site

      Lonza Expands Development, Mfg. Capabilities at Bend Site

      Investment will add 11 new suites for particle engineering and drug product capacity to improve program lead times.
      Contract Pharma Staff 11.30.20

    • Analytical Services | Breaking News | Formulation Development | Industry News | Laboratory Testing
      Cambrex Completes Edinburgh Expansion

      Cambrex Completes Edinburgh Expansion

      Doubles the facility's footprint to 15,000 sq.-ft., existing lab space is refurbished, and an additional 3,500 sq.-ft. of lab space added.
      Contract Pharma Staff 10.12.20


    • Breaking News | cGMP Manufacture | Formulation Development | Industry News | Scale-up/Technology Transfer
      Catalent Launches OneXpress Solution

      Catalent Launches OneXpress Solution

      Aims to accelerate a program’s transition from early-phase development to commercial-ready manufacturing for oral dosage products.
      Contract Pharma Staff 10.01.20

    • Breaking News | cGMP Manufacture | Formulation Development | Industry News | Process Development
      Thomas Lee Partners, Frazier Healthcare Acquires Adare Pharmaceuticals

      Thomas Lee Partners, Frazier Healthcare Acquires Adare Pharmaceuticals

      Includes Adare’s CDMO, pharmaceutical technology and microbiome businesses; will rebrand as Adare Pharma Solutions.
      Contract Pharma Staff 09.30.20

    • APIs | Breaking News | cGMP Manufacture | Chemistry | Drug Development | Excipients | Formulation Development | Industry News
      Piramal to Deliver Integrated Services to Epirium

      Piramal to Deliver Integrated Services to Epirium

      Includes formulation development, supply of APIs and intermediates, chemistry development and manufacturing, and solid oral dosage form drug product.
      Contract Pharma Staff 08.27.20


    • Breaking News | Collaborations & Alliances | Formulation Development
      TFF Pharmaceuticals Signs Worldwide Licensing Agreement with Union Therapeutics

      TFF Pharmaceuticals Signs Worldwide Licensing Agreement with Union Therapeutics

      Will develop dry powder forms of niclosamide as a potential COVID-19 treatment.
      Contract Pharma Staff 08.17.20

    • Biologics, Proteins, Vaccines | Breaking News | Fill/Finish | Formulation Development | Industry News
      Dalton, VIDO-InterVac Partner to Develop COVID-19 Vax

      Dalton, VIDO-InterVac Partner to Develop COVID-19 Vax

      Dalton to provide formulation and fill/finish of VIDO-InterVac’s COVID-19 vaccine to be used in early phase clinical trials.
      Contract Pharma Staff 07.28.20

    • Breaking News | Drug Development | Formulation Development | Industry News | Laboratory Testing | Methods Development
      MilliporeSigma Opens M Lab Collaboration Center in Shanghai

      MilliporeSigma Opens M Lab Collaboration Center in Shanghai

      Offers customizable solutions to help advance drug development, including pilot scale and process development support labs that offer non-GMP lab space.
      Contract Pharma Staff 07.10.20

    Trending
    • Four Female Leaders Appointed To Cell & Gene CDMO
    • BMS Expands Cell Therapy Manufacturing Capabilities
    • Reed-Lane Facility Virtual Tour
    Breaking News
    • Jubilant Therapeutics Appoints Chief Scientific Officer
    • Iontas and Fair Journey Biologics Partner with Quell Therapeutics
    • Vetter Establishes Office in China
    • AGC Biologics Expands Cell and Gene Facility in Italy
    • Celonic to Boost Cell & Gene Therapy Production
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • Hygienic Packaging Technology
    • Trends in Solid Oral Dosage Delivery
    • 5 Reasons Paper Has No Place in Contract Manufacturing
    • Injectable Drug Delivery Trends
    • Pharmaceutical Manufacturing Equipment Trends
    • Oral Solids: Market & Technology Trends
    • Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow
    • 2021 Contract Manufacturing Survey
    • Small Molecule Development Trends
    • Challenges & Opportunities Facing Small & Emerging Biopharma Companies
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Thymoquinone Inhibits Viral Infection in In Vitro Settings, New Study Finds
    IFT Transitions 2021 Annual Event to Digital Experience
    NY Federal Judge Enters Permanent Injunction Against Dietary Supplement Manufacturer
    Coatings World

    Latest Breaking News From Coatings World

    Sherwin-Williams Announces Resignation of President, COO
    Ashland Completes Expansion, Relocation of Viatel Bioresorbable Polymers Manufacturing Facility
    Evonik Receives Sustainability Award from EcoVadis
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Avacta’s Rapid Antigen Test Proves Effective for New Coronavirus Variants
    Cretex CFO Announces Retirement
    New AI-Based Tool Developed for Coronary Artery Analysis, Intervention Planning
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Jubilant Therapeutics Appoints Chief Scientific Officer
    Iontas and Fair Journey Biologics Partner with Quell Therapeutics
    Vetter Establishes Office in China
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    e.l.f. Cosmetics and Chipotle Collaborate on Burrito-Inspired Makeup Collection
    Weekly Recap: Sephora Expansion, Ulta Partners with Loop, International Women’s Day & More
    Ulta Beauty Opens in Herald Square
    Happi

    Latest Breaking News From Happi

    Batiste Rolls Out Wonder Woman Dry Shampoo
    Erno Laszlo Taps Carina Lau as Global Spokesperson
    It's International Women's Day
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Epson reveals new ink for ColorWorks C6000-Series label printers
    VPF launches liner made from recycled paper
    Cartes engineers inkjet embellishment technology
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Kimberly-Clark Names Chief Research and Development Officer
    FPInnovations Develops Biodegradable Mask
    Sani Professional Sanitizing and Disinfecting Products Approved by EPA
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Colfax Decides to Divide Its Businesses
    Stryker Corp.'s 2020 Sales Slip 3.6 Percent
    Bioventus Appoints Managing Director, China and Asia Pacific
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login